Cite
Clarithromycin Versus Metronidazole as First-line Helicobacter pylori Eradication: A Multicenter, Prospective, Randomized Controlled Study in Japan.
MLA
Nishizawa, Toshihiro, et al. “Clarithromycin Versus Metronidazole as First-Line Helicobacter Pylori Eradication: A Multicenter, Prospective, Randomized Controlled Study in Japan.” Journal of Clinical Gastroenterology, vol. 49, no. 6, July 2015, pp. 468–71. EBSCOhost, https://doi.org/10.1097/MCG.0000000000000165.
APA
Nishizawa, T., Maekawa, T., Watanabe, N., Harada, N., Hosoda, Y., Yoshinaga, M., Yoshio, T., Ohta, H., Inoue, S., Toyokawa, T., Yamashita, H., Saito, H., Kuwai, T., Katayama, S., Masuda, E., Miyabayashi, H., Kimura, T., Nishizawa, Y., Takahashi, M., & Suzuki, H. (2015). Clarithromycin Versus Metronidazole as First-line Helicobacter pylori Eradication: A Multicenter, Prospective, Randomized Controlled Study in Japan. Journal of Clinical Gastroenterology, 49(6), 468–471. https://doi.org/10.1097/MCG.0000000000000165
Chicago
Nishizawa, Toshihiro, Takama Maekawa, Noriko Watanabe, Naohiko Harada, Yasuo Hosoda, Masahiro Yoshinaga, Toshiyuki Yoshio, et al. 2015. “Clarithromycin Versus Metronidazole as First-Line Helicobacter Pylori Eradication: A Multicenter, Prospective, Randomized Controlled Study in Japan.” Journal of Clinical Gastroenterology 49 (6): 468–71. doi:10.1097/MCG.0000000000000165.